factually
Index/Topics/Ivermectin for Cancer Treatment 2025

Ivermectin for Cancer Treatment 2025

The use of ivermectin in cancer treatment, specifically in a Phase I/II trial for metastatic triple-negative breast cancer, as of 2025.

Fact-Checks

2 results
Jan 7, 2026
Most Viewed

What known drug–drug interactions exist between ivermectin and common chemotherapy or targeted agents?

Preclinical literature shows repeated, drug‑level interactions between ivermectin and multiple chemotherapy or targeted agents—mostly beneficial pharmacodynamic synergies (enhanced tumor cell kill, re...

Jan 6, 2026

What clinical trials registered in ClinicalTrials.gov are testing ivermectin for cancer as of 2025?

As of 2025, ClinicalTrials.gov shows a single registered interventional study testing ivermectin for cancer: a Phase I/II trial (NCT05318469) combining oral ivermectin with an immune checkpoint inhibi...